Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction.
about
Lentiviral vectors can be used for full-length dystrophin gene therapySingle Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy.Sustained expression of insulin by a genetically engineered sertoli cell line after allotransplantation in diabetic BALB/c miceBCR-JAK2 drives a myeloproliferative neoplasm in transplanted mice.Lentiviral transduction of CD34(+) cells induces genome-wide epigenetic modifications.Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant.Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFPFIREWACh: high-throughput functional detection of transcriptional regulatory modules in mammalian cells.Optimised concentration and purification of retroviruses using membrane chromatographyVectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells.Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytesConcurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of transduction enhancersInduced neural lineage cells as repair kits: so close, yet so far away.Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors.Transduction of hematopoietic stem cells to stimulate RNA interference against feline infectious peritonitis.Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products.Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy.Application of Droplet Digital PCR for Estimating Vector Copy Number States in Stem Cell Gene TherapyLentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.Safe and Efficient Gene Therapy for Pyruvate Kinase DeficiencyA two-compartment microfluidic device for long-term live cell detection based on surface plasmon resonance.Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients.Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.Exon Specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a Familial Dysautonomia mouse model.Lentiviral vectors can be used for full-length dystrophin gene therapy.Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency.Plasmid-normalized quantification of relative mitochondrial DNA copy number
P2860
Q33668822-328ED3EB-5457-467D-887C-860EC01D87E5Q33784306-FBFB8945-6756-4C4C-8959-F64145522479Q33826170-C8492DBB-3B40-4068-AC8D-CEB717EE549AQ34461890-D23EB4D2-5AAB-4B89-82AA-B09A8F406993Q34473789-E9C4B031-01EE-46CA-8EB8-1FE434921EA9Q34745316-6996EF47-6DB1-4F7C-BDC9-5B81FFD12CF8Q35049552-E8EA0577-45C7-4A40-9EC5-FE44B3639A53Q35128053-F9BD2D14-9498-44AF-9E51-6BBD404DF74DQ35135764-D3015847-B428-4A7A-B9F2-E2196531CEEBQ36757162-4060919E-64FD-4B89-B24E-470CF9D2304DQ37089728-B26527D0-C5A8-4CA9-AD2A-A86E27F40452Q37358371-7A217137-5ECC-4290-BEC3-CCA5359CF5B1Q37633922-CF6B681D-54FA-484C-B548-D0E60998FC2CQ38163443-9A264B36-1ACB-44D2-84D8-E146D0DCED1EQ38734590-D19CCD83-ED03-4BEE-A8E3-EEF041701E7EQ38761107-E04403A2-4503-454F-9C5C-04FBD65ED4C0Q40107296-4A438E43-B257-4680-8F26-66488395D5DAQ40183063-8B86B80F-EE8E-4444-BB34-843913A80A8FQ40414488-12D645C4-6658-40E0-B51D-2AA4C99B6CB5Q40545682-18B08A98-7E3A-4C5D-9241-28FA70876C30Q40772336-080B1036-04FE-4756-9E10-349D388594BDQ41763755-3E36CDA1-129C-44FD-A9F2-4241FBE0D68FQ45861515-6E67B7FD-CEFC-4C40-87FE-B1E3A3F6075FQ45871852-5742F6E9-C594-4D39-B675-DE548B8F6BE2Q45875615-5DF980DB-F509-4480-941B-37E5FA7AAB03Q52559115-71E573DA-166C-4024-A548-37C45CFDD9A3Q53426367-12C07B67-ED97-4CD4-80A8-093B601660BCQ55165596-F269A350-C234-4FFC-9CC1-5DE6B13FF561Q58603710-0E0ACCCD-90B1-4FD5-949D-BB090FE10405
P2860
Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Quantification of lentiviral v ...... ncy and level of transduction.
@ast
Quantification of lentiviral v ...... ncy and level of transduction.
@en
type
label
Quantification of lentiviral v ...... ncy and level of transduction.
@ast
Quantification of lentiviral v ...... ncy and level of transduction.
@en
prefLabel
Quantification of lentiviral v ...... ncy and level of transduction.
@ast
Quantification of lentiviral v ...... ncy and level of transduction.
@en
P2093
P2860
P356
P1433
P1476
Quantification of lentiviral v ...... ency and level of transduction
@en
P2093
A Viornery
G Précigout
O W Merten
S Bucher-Laurent
S Charrier
P2860
P2888
P304
P356
10.1038/GT.2010.163
P577
2010-12-16T00:00:00Z